The lack of utility of circulating biomarkers of inflammation and endothelial dysfunction for type 2 diabetes risk prediction among postmenopausal women: The women's health initiative observational study

Archives of Internal Medicine

Volumn 170, Issue 17, 2010, Pages 1557-1565

  Chao, Chun ^a   Song, Yiqing ^b   Cook, Nancy ^b,c   Tseng, Chi Hong ^d   Manson, JoAnn E ^b,c   Eaton, Charles ^g   Margolis, Karen L ^h   Rodriguez, Beatriz ⁱ   Phillips, Lawrence S ^j,k   Tinker, Lesley F ^l   Liu, Simin ^d,e,f  

^a KAISER PERMANENTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g BROWN UNIVERSITY   (United States)

^h HEALTHPARTNERS RESEARCH FOUNDATION   (United States)

ⁱ UNIVERSITY OF HAWAII   (United States)

^j EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k ATLANTA VA MEDICAL CENTER   (United States)

^l USA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GLUCOSE; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; TUMOR NECROSIS FACTOR RECEPTOR 2; VASCULAR CELL ADHESION MOLECULE 1; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; FEMALE; FREQUENCY DISCRIMINATION; GLUCOSE BLOOD LEVEL; HUMAN; INFLAMMATION; INSULIN BLOOD LEVEL; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; POSTMENOPAUSE; PREDICTION AND FORECASTING; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; BLOOD; CASE CONTROL STUDY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROSPECTIVE STUDY; RISK ASSESSMENT; VASCULAR ENDOTHELIUM;

AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; E-SELECTIN; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INFLAMMATION; INSULIN; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; LEUKOCYTE COUNT; MIDDLE AGED; POSTMENOPAUSE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; RISK ASSESSMENT; VASCULAR CELL ADHESION MOLECULE-1;

EID: 77957666215     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2010.312     Document Type: Article

References (47)

1. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: General Information and National Estimate on Diabetes in the United States, 2005. Atlanta, GA: Centers for Disease Control and Prevention, US Dept of Health and Human Services; 2006.
2. Centers for Disease Control and Prevention. National Diabetes Factsheet, 2007. Atlanta, GA: Centers for Disease Control and Prevention, US Dept of Health and Human Services; 2008.
3. Narayan KM, Boyle JP, Geiss LS, Saaddine JB, Thompson TJ. Impact of recent increase in incidence on future diabetes burden: US, 2005-2050. Diabetes Care. 2006;29(9):2114-2116.
4. Orchard TJ, Temprosa M, Goldberg R, et al; Diabetes Prevention Program Research Group. The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial. Ann Intern Med. 2005;142(8):611-619.
5. Wylie-Rosett J, Herman WH, Goldberg RB. Lifestyle intervention to prevent diabetes: intensive and cost effective. Curr Opin Lipidol. 2006;17(1):37-44.
6. Barzilay JI, Abraham L, Heckbert SR, et al. The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes. 2001;50(10):2384-2389. (Pubitemid 33641926)
7. Duncan BB, Schmidt MI, Pankow JS, et al; Atherosclerosis Risk in Communities Study. Low-grade systemic inflammation and the development of type 2 diabetes: the Atherosclerosis Risk in Communities Study. Diabetes. 2003;52(7):1799-1805.
8. Festa A, D'Agostino R Jr, Tracy RP, Haffner SM; Insulin Resistance Atherosclerosis Study. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the Insulin Resistance Atherosclerosis Study. Diabetes. 2002;51(4):1131-1137. (Pubitemid 34438360)
9. Ford ES. Leukocyte count, erythrocyte sedimentation rate, and diabetes incidence in a national sample of US adults. Am J Epidemiol. 2002;155(1):57-64.
10. Freeman DJ, Norrie J, Caslake MJ, et al; West of Scotland Coronary Prevention Study. C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes. 2002;51(5):1596-1600.
11. Han TS, Sattar N, Williams K, Gonzalez-Villalpando C, Lean ME, Haffner SM. Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diabetes Care. 2002;25(11):2016-2021. (Pubitemid 41071061)
12. Hu FB, Meigs JB, Li TY, Rifai N, Manson JE. Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes. 2004;53(3):693-700. (Pubitemid 38270639)
13. Laaksonen DE, Niskanen L, Nyyssönen K, et al. C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men. Diabetologia. 2004;47(8):1403-1410.
14. Liu S, Tinker L, Song Y, et al. A prospective study of inflammatory cytokines and diabetes mellitus in a multiethnic cohort of postmenopausal women. Arch Intern Med. 2007;167(15):1676-1685.
15. Nakanishi N, Yoshida H, Matsuo Y, Suzuki K, Tatara K. White blood-cell count and the risk of impaired fasting glucose or type II diabetes in middle-aged Japanese men. Diabetologia. 2002;45(1):42-48. (Pubitemid 34118541)
16. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001;286(3):327-334. (Pubitemid 32656163)
17. Spranger J, Kroke A, Möhlig M, et al. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes. 2003;52(3):812-817.
18. Thorand B, Löwel H, Schneider A, et al. C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984-1998. Arch Intern Med. 2003;163(1):93-99.
19. Schmidt MI, Duncan BB, Sharrett AR, et al. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities Study): a cohort study. Lancet. 1999;353(9165):1649-1652.
20. Meigs JB, Hu FB, Rifai N, Manson JE. Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA. 2004;291(16):1978-1986. (Pubitemid 38544279)
21. Song Y, Manson JE, Tinker L, et al. Circulating levels of endothelial adhesion molecules and risk of diabetes in an ethnically diverse cohort of women. Diabetes. 2007;56(7):1898-1904. (Pubitemid 47025455)
22. Thorand B, Baumert J, Chambless L, et al; MONICA/KORA Study Group. Elevated markers of endothelial dysfunction predict type 2 diabetes mellitus in middle-aged men and women from the general population. Arterioscler Thromb Vasc Biol. 2006;26(2):398-405. (Pubitemid 43732206)
23. Anderson GL, Manson J, Wallace R, et al. Implementation of the Women's Health Initiative study design. Ann Epidemiol. 2003;13(9)(suppl):S5-S17. (Pubitemid 37324175)
24. Meyer AM, Evenson KR, Morimoto L, Siscovick D, White E. Test-retest reliability of the Women's Health Initiative physical activity questionnaire. Med Sci Sports Exerc. 2009;41(3):530-538.
25. Patterson RE, Kristal AR, Tinker LF, Carter RA, Bolton MP, Agurs-Collins T. Measurement characteristics of the Women's Health Initiative Food Frequency Questionnaire. Ann Epidemiol. 1999;9(3):178-187. (Pubitemid 29144458)
26. Song Y, Manson JE, Tinker L, et al. Insulin sensitivity and insulin secretion determined by homeostasis model assessment and risk of diabetes in a multiethnic cohort of women: the Women's Health Initiative Observational Study. Diabetes Care. 2007;30(7):1747-1752. (Pubitemid 47036347)
27. Royston P, Ambler G, Sauerbrei W. The use of fractional polynomials to model continuous risk variables in epidemiology. Int J Epidemiol. 1999;28(5):964-974. (Pubitemid 29525041)
28. Hosmer DW, Lemeshow S. Logistic regression for matched case-control studies. In: Applied Logistic Regression. New York, NY: John Wiley & Sons Inc; 1989:187-213.
29. Rubin DB. Multiple Imputation for Nonresponse in Surveys. New York, NY: John Wiley & Sons Inc; 1987.
30. Wannamethee SG, Shaper AG, Lennon L, Morris RW. Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med. 2005;165(22):2644-2650.
31. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837-1847.
32. Langholz B, Borgan O. Estimation of absolute risk from nested case-control data. Biometrics. 1997;53(2):767-774. (Pubitemid 27262238)
33. Langholz B. Use of cohort information in the design and analysis of case-control studies. Scand J Stat. 2007;34(1):120-136. doi:10.1111/j.1467-9469. 2006.00548.x.
34. Cook NR, Buring JE, Ridker PM. The effect of including C-reactive protein in cardiovascular risk prediction models for women. Ann Intern Med. 2006;145(1):21-29. (Pubitemid 46780601)
35. Ridker PM, Buring JE, Rifai N, Cook NR. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA. 2007;297(6):611-619. (Pubitemid 46257283)
36. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27(2):157-172, 207-212.
37. McNeely MJ, Boyko EJ, Leonetti DL, Kahn SE, Fujimoto WY. Comparison of a clinical model, the oral glucose tolerance test, and fasting glucose for prediction of type 2 diabetes risk in Japanese Americans. Diabetes Care. 2003;26(3):758-763.
38. Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 2005;112(20):3066-3072. (Pubitemid 43113437)
39. Hanley AJ, Karter AJ, Williams K, et al. Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the Insulin Resistance Atherosclerosis Study. Circulation. 2005;112(24):3713-3721. (Pubitemid 43739511)
40. Ware JH. The limitations of risk factors as prognostic tools. N Engl J Med. 2006; 355(25):2615-2617. (Pubitemid 44969120)
41. Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation. 2007;115(7):928-935.
42. Cook NR. Comments on "Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond" by M. J. Pencina et al. Statistics in Medicine (DOI: 10.1002/sim.2929). Stat Med. 2008;27(2):191-195. (Pubitemid 351193644)
43. Greenland S. The need for reorientation toward cost-effective prediction: comments on "Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond" by M. J. Pencina et al. Statistics in Medicine (DOI: 10.1002/sim.2929) [published correction appears in Stat Med. 2008;27(2):316]. Stat Med. 2008;27(2):199-206.
44. Griffin SJ, Little PS, Hales CN, Kinmonth AL, Wareham NJ. Diabetes risk score: towards earlier detection of type 2 diabetes in general practice. Diabetes Metab Res Rev. 2000;16(3):164-171. (Pubitemid 30410271)
45. Schmidt MI, Duncan BB, Bang H, et al; Atherosclerosis Risk in Communities Investigators. Identifying individuals at high risk for diabetes: the Atherosclerosis Risk in Communities Study. Diabetes Care. 2005;28(8):2013-2018.
46. Stern MP, Williams K, Haffner SM. Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test? Ann Intern Med. 2002;136(8):575-581. (Pubitemid 34407041)
47. Steyerberg EW, Harrell FE Jr, Borsboom GJ, Eijkemans MJ, Vergouwe Y, Habbema JD. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol. 2001;54(8):774-781. (Pubitemid 32722180)